AUTHOR=Leitner Theo , Shumilov Evgenii , Schwitlick Christina , Koch Raphael , Hamm Franziska , Högner Marion , Bassermann Florian , Weisel Katja , Einsele Hermann , Kortüm Martin , Rasche Leo , Görner Martin , Wegehenkel Kai , Knop Stefan , Krönke Jan , Nogai Axel , König Inke R. , Vens Maren , Horn Kay , von Bubnoff Nikolas , Khandanpour Cyrus 

TITLE=Comparison of 6 cycles of isatuximab with lenalidomide, bortezomib and dexamethasone (I-VRd) versus 3 cycles of I-VRd followed by one cycle of high-dose melphalan in newly diagnosed low-risk multiple myeloma. Protocol for a multicenter, prospective, randomized, phase II clinical trial (ELIAS-Trial)

JOURNAL=Frontiers in Hematology

VOLUME=3

YEAR=2024

URL=https://www.frontiersin.org/journals/hematology/articles/10.3389/frhem.2024.1436845

DOI=10.3389/frhem.2024.1436845

ISSN=2813-3935